It may not have been pretty, but Regulus Therapeutics ($RGLS) raised close to $81 million from its recent IPO and some related transactions. And the company did it with a big assist from some major league partners in the biopharma industry. Report
| NOW AVAILABLE ON-DEMAND | Presented By: BBK Worldwide
BBK Worldwide hosts a webinar exploring this new connected health model and its impact on clinical research. Join their expert panel, which includes mHealth experts from BBK Worldwide, Oracle and Empatica, and learn key strategies for successful implementation. Registration is free – click here.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!